Table: Daito -Q1 group results

Daito Pharmaceutical

13/10/2022 07:00

Oct 13 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2022        Aug 31, 2021     May 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             12.04               11.75            44.00    
                 (+2.5 pct)                           (+1.2 pct)  
  Operating          1.50                2.36             4.50    
                 (-36.4 pct)         (+21.2 pct)      (-31.3 pct) 
  Recurring          1.48                2.42             4.60    
                 (-39.0 pct)         (+23.1 pct)      (-31.6 pct) 
  Net              946 mln               1.83             3.20    
                 (-48.2 pct)         (+38.1 pct)      (-31.5 pct) 
  EPS             65.71 yen          133.09 yen       222.72 yen  
  Ann Div                             60.00 yen        60.00 yen  
  -Q2 div                             25.00 yen        30.00 yen  
  -Q4 div                             35.00 yen        30.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T